What are the Challenges in Developing INDs for Cancer?
Developing INDs for cancer presents several challenges, including:
- Complexity of Cancer Biology: Cancer is a highly heterogeneous disease, making it difficult to develop a one-size-fits-all treatment. - Safety Concerns: Ensuring that new treatments do not cause undue harm to patients is paramount. - Regulatory Hurdles: Navigating the regulatory landscape can be time-consuming and costly. - Financial Costs: Drug development is an expensive process, often requiring significant investment in research and development.
